{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:18:12Z","timestamp":1787163492413,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12602-024-10360-x","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T21:02:06Z","timestamp":1725915726000},"page":"4111-4123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Oral Live-Carrier Vaccine of Recombinant Lactococcus lactis Inducing Prophylactic Protective Immunity Against Helicobacter pylori Infection"],"prefix":"10.1007","volume":"17","author":[{"given":"Xiumei","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingxin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7460-5040","authenticated-orcid":false,"given":"Kaiyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"issue":"5","key":"10360_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1080\/1040841X.2017.1291578","volume":"43","author":"N Mirzaei","year":"2017","unstructured":"Mirzaei N, Poursina F, Moghim S et al (2017) The study of H. pylori putative candidate factors for single- and multi-component vaccine development. Crit Rev Microbiol 43(5):631\u2013650. https:\/\/doi.org\/10.1080\/1040841X.2017.1291578","journal-title":"Crit Rev Microbiol"},{"issue":"3","key":"10360_CR2","doi-asserted-by":"publisher","first-page":"CD012080","DOI":"10.1002\/14651858.CD012080.pub2","volume":"3","author":"LM Best","year":"2018","unstructured":"Best LM, Takwoingi Y, Siddique S et al (2018) Non-invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database Syst Rev 3(3):CD012080. https:\/\/doi.org\/10.1002\/14651858.CD012080.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"10360_CR3","doi-asserted-by":"publisher","first-page":"938608","DOI":"10.3389\/fcimb.2022.938608","volume":"12","author":"WT Xu","year":"2022","unstructured":"Xu WT, Xu LM, Xu CF (2022) Relationship between Helicobacter pylori infection and gastrointestinal microecology. Front Cell Infect Microbiol 12:938608\u2013938618. https:\/\/doi.org\/10.3389\/fcimb.2022.938608","journal-title":"Front Cell Infect Microbiol"},{"key":"10360_CR4","first-page":"1","volume":"61","author":"IARC Working Group","year":"1994","unstructured":"IARC Working Group (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 61:1\u2013241","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"issue":"12","key":"10360_CR5","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1136\/gutjnl-2020-322368","volume":"69","author":"JM Liou","year":"2020","unstructured":"Liou JM, Malfertheiner P, Lee YC et al (2020) Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut 69(12):2093\u20132112. https:\/\/doi.org\/10.1136\/gutjnl-2020-322368","journal-title":"Gut"},{"issue":"1","key":"10360_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/j.gastro.2022.03.039","volume":"163","author":"LG Yan","year":"2022","unstructured":"Yan LG, Chen Y, Chen F et al (2022) Effect of Helicobacter pylori eradication on gastric cancer prevention: updated report from a randomized controlled trial with 26.5 years of follow-up. Gastroenterology 163(1):154\u2013162. https:\/\/doi.org\/10.1053\/j.gastro.2022.03.039","journal-title":"Gastroenterology"},{"issue":"10","key":"10360_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S2468-1253(18)30125-0","volume":"3","author":"P Malfertheiner","year":"2018","unstructured":"Malfertheiner P, Selgrad M, Wex T et al (2018) Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1\/2 study. Lancet Gastroenterol Hepatol 3(10):698\u2013707. https:\/\/doi.org\/10.1016\/S2468-1253(18)30125-0","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10360_CR8","doi-asserted-by":"publisher","first-page":"e12638","DOI":"10.1111\/hel.12736","volume":"24","author":"M Denic","year":"2019","unstructured":"Denic M, Touati E, De Reuse H (2019) Review: pathogenesis of Helicobacter pylori infection. Helicobacter 24(Suppl 1):e12638. https:\/\/doi.org\/10.1111\/hel.12736","journal-title":"Helicobacter"},{"key":"10360_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jare.2018.01.006","volume":"13","author":"DY Graham","year":"2018","unstructured":"Graham DY, Miftahussurur M (2018) Helicobacter pylori urease for diagnosis of Helicobacter pylori infection: a mini review. J Adv Res 13:51\u201357. https:\/\/doi.org\/10.1016\/j.jare.2018.01.006","journal-title":"J Adv Res"},{"issue":"10002","key":"10360_CR10","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0140-6736(15)60310-5","volume":"386","author":"M Zeng","year":"2015","unstructured":"Zeng M, Mao XH, Li JX et al (2015) Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 386(10002):1457\u20131464. https:\/\/doi.org\/10.1016\/S0140-6736(15)60310-5","journal-title":"Lancet"},{"issue":"1","key":"10360_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.imlet.2005.10.016","volume":"103","author":"E Hifumi","year":"2006","unstructured":"Hifumi E, Yamada Y, Uda T (2006) A catalytic antibody heavy chain HpU-2 degrading its epitope peptide and H. pylori urease. Immunol Lett 103(1):68\u201374. https:\/\/doi.org\/10.1016\/j.imlet.2005.10.016","journal-title":"Immunol Lett"},{"issue":"6","key":"10360_CR12","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00253-012-4122-0","volume":"95","author":"L Guo","year":"2012","unstructured":"Guo L, Liu KM, Xu GX et al (2012) Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB\/c mice model. Appl Microbiol Biotechnol 95(6):1437\u20131444. https:\/\/doi.org\/10.1007\/s00253-012-4122-0","journal-title":"Appl Microbiol Biotechnol"},{"issue":"22","key":"10360_CR13","doi-asserted-by":"publisher","first-page":"9495","DOI":"10.1007\/s00253-015-6705-z","volume":"99","author":"H Song","year":"2015","unstructured":"Song H, Lv XB, Yang J et al (2015) A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB\/c mouse model. Appl Microbiol Biotechnol 99(22):9495\u20139502. https:\/\/doi.org\/10.1007\/s00253-015-6705-z","journal-title":"Appl Microbiol Biotechnol"},{"issue":"5","key":"10360_CR14","doi-asserted-by":"publisher","first-page":"e12426","DOI":"10.1111\/hel.12426","volume":"22","author":"W Liu","year":"2017","unstructured":"Liu W, Tan ZL, Liu H et al (2017) Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori. Helicobacter 22(5):e12426. https:\/\/doi.org\/10.1111\/hel.12426","journal-title":"Helicobacter"},{"issue":"8","key":"10360_CR15","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.vaccine.2010.11.091","volume":"29","author":"VP da Hora","year":"2011","unstructured":"da Hora VP, Conceicao FR, Dellagostin OA et al (2011) Non-toxic derivatives of LT as potent adjuvants. Vaccine 29(8):1538\u20131544. https:\/\/doi.org\/10.1016\/j.vaccine.2010.11.091","journal-title":"Vaccine"},{"issue":"11","key":"10360_CR16","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3390\/vaccines9111213","volume":"9","author":"G Zerna","year":"2021","unstructured":"Zerna G, Rathinasamy VA, Toet H et al (2021) Evaluation of immunogenicity and efficacy of fasciola hepatica Tetraspanin 2 (TSP2) fused to E. coli heat-labile enterotoxin B subunit LTB adjuvant following intranasal vaccination of cattle. Vaccines 9(11):1213\u20131230. https:\/\/doi.org\/10.3390\/vaccines9111213","journal-title":"Vaccines"},{"issue":"1","key":"10360_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12026-017-8953-8","volume":"66","author":"M Sharma","year":"2018","unstructured":"Sharma M, Dash P, Sahoo PK et al (2018) Th2-biased immune response and agglutinating antibodies generation by a chimeric protein comprising OmpC epitope (323\u2013336) of Aeromonas hydrophila and LTB. Immunol Res 66(1):187\u2013199. https:\/\/doi.org\/10.1007\/s12026-017-8953-8","journal-title":"Immunol Res"},{"issue":"3","key":"10360_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.4161\/gmic.24197","volume":"4","author":"Z Qing","year":"2014","unstructured":"Qing Z, Berzofsky JA (2014) Oral vaccines: directed safe passage to the front line of defense. Gut Microbes 4(3):246\u2013252. https:\/\/doi.org\/10.4161\/gmic.24197","journal-title":"Gut Microbes"},{"issue":"13","key":"10360_CR19","doi-asserted-by":"publisher","first-page":"918160","DOI":"10.3389\/fimmu.2022.918160","volume":"13","author":"L Guo","year":"2022","unstructured":"Guo L, Zhang FR, Wang SE et al (2022) Oral immunization with a M cell-targeting recombinant L. lactis vaccine LL-plSAM-FVpE stimulate protective immunity against H. pylori in mice. Front Immunol 13(13):918160\u2013918172. https:\/\/doi.org\/10.3389\/fimmu.2022.918160","journal-title":"Front Immunol"},{"issue":"5\u20136","key":"10360_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/s0264-410x(99)00246-7","volume":"18","author":"MD DiPetrillo","year":"1999","unstructured":"DiPetrillo MD, Tibbetts T, Kleanthous H et al (1999) Safety and immunogenicity of phoP\/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. Vaccine 18(5\u20136):449\u2013459. https:\/\/doi.org\/10.1016\/s0264-410x(99)00246-7","journal-title":"Vaccine"},{"issue":"9","key":"10360_CR21","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/intimm\/dxu063","volume":"26","author":"T Azegami","year":"2014","unstructured":"Azegami T, Yuki Y, Kiyono H (2014) Challenges in mucosal vaccines for the control of infectious diseases. Int Immunol 26(9):517\u2013528. https:\/\/doi.org\/10.1093\/intimm\/dxu063","journal-title":"Int Immunol"},{"issue":"1","key":"10360_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12934-017-0669-x","volume":"16","author":"AA Song","year":"2017","unstructured":"Song AA, In LLA, Lim SHE et al (2017) A review on Lactococcus lactis: from food to factory. Microb Cell Fact 16(1):55\u201369. https:\/\/doi.org\/10.1186\/s12934-017-0669-x","journal-title":"Microb Cell Fact"},{"issue":"1","key":"10360_CR23","doi-asserted-by":"publisher","first-page":"2110821","DOI":"10.1080\/19490976.2022.2110821","volume":"14","author":"R Levit","year":"2022","unstructured":"Levit R, Cortes-Perez NG, de Moreno de Leblanc A, et al (2022) Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health. Gut Microbes 14(1):2110821\u20132110842. https:\/\/doi.org\/10.1080\/19490976.2022.2110821","journal-title":"Gut Microbes"},{"issue":"1","key":"10360_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12602-020-09684-1","volume":"13","author":"H Shirdast","year":"2021","unstructured":"Shirdast H, Ebrahimzadeh F, Taromchi AH et al (2021) Recombinant Lactococcus lactis displaying Omp31 antigen of Brucella melitensis can induce an immunogenic response in BALB\/c mice. Probiotics Antimicrob Proteins 13(1):80\u201389. https:\/\/doi.org\/10.1007\/s12602-020-09684-1","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"5","key":"10360_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4161\/bbug.1.5.12086","volume":"1","author":"MS Medina","year":"2014","unstructured":"Medina MS, Vinti\u00f1i EO, Villena J et al (2014) Lactococcus lactis as an adjuvant and delivery vehicle of antigens against pneumococcal respiratory infections. Bioengineered Bugs 1(5):313\u2013325. https:\/\/doi.org\/10.4161\/bbug.1.5.12086","journal-title":"Bioengineered Bugs"},{"issue":"1","key":"10360_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mcp.2013.08.003","volume":"28","author":"HX Zhang","year":"2014","unstructured":"Zhang HX, Qiu YY, Zhao YH et al (2014) Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant. Mol Cell Probes 28(1):25\u201330. https:\/\/doi.org\/10.1016\/j.mcp.2013.08.003","journal-title":"Mol Cell Probes"},{"issue":"6","key":"10360_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.4161\/bioe.23574","volume":"4","author":"MAR Amalaradjou","year":"2014","unstructured":"Amalaradjou MAR, Bhunia AK (2014) Bioengineered probiotics, a strategic approach to control enteric infections. Bioengineered 4(6):379\u2013387. https:\/\/doi.org\/10.4161\/bioe.23574","journal-title":"Bioengineered"},{"issue":"10","key":"10360_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/protein\/gzu043","volume":"27","author":"JS Klein","year":"2014","unstructured":"Klein JS, Jiang S, Galimidi RP et al (2014) Design and characterization of structured protein linkers with differing flexibilities. Protein Eng Des Sel 27(10):325\u2013330. https:\/\/doi.org\/10.1093\/protein\/gzu043","journal-title":"Protein Eng Des Sel"},{"key":"10360_CR29","doi-asserted-by":"publisher","first-page":"1098365","DOI":"10.3389\/fmolb.2023.1098365","volume":"10","author":"Y Ahmadi Moghaddam","year":"2023","unstructured":"Ahmadi Moghaddam Y, Maroufi A, Zareei S et al (2023) Computational design of fusion proteins against ErbB2-amplified tumors inspired by ricin toxin. Front Mol Biosci 10:1098365\u20131098374. https:\/\/doi.org\/10.3389\/fmolb.2023.1098365","journal-title":"Front Mol Biosci"},{"issue":"14","key":"10360_CR30","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1128\/jb.183.14.4157-4166.2001","volume":"183","author":"Y Dieye","year":"2001","unstructured":"Dieye Y, Usai S, Clier F et al (2001) Design of a protein-targeting system for lactic acid bacteria. J Bacteriol 183(14):4157\u20134166. https:\/\/doi.org\/10.1128\/jb.183.14.4157-4166.2001","journal-title":"J Bacteriol"},{"issue":"12","key":"10360_CR31","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1128\/aem.55.12.3119-3123","volume":"55","author":"H Holo","year":"1989","unstructured":"Holo H, Nes IF (1989) High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl Environ Microbiol 55(12):3119\u20133123. https:\/\/doi.org\/10.1128\/aem.55.12.3119-3123","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"10360_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12934-016-0506-7","volume":"15","author":"B Zhang","year":"2016","unstructured":"Zhang B, Li AD, Zuo FL et al (2016) Recombinant Lactococcus lactis NZ9000 secretes a bioactive kisspeptin that inhibits proliferation and migration of human colon carcinoma HT-29 cells. Microb Cell Fact 15(1):102\u2013112. https:\/\/doi.org\/10.1186\/s12934-016-0506-7","journal-title":"Microb Cell Fact"},{"key":"10360_CR33","doi-asserted-by":"publisher","first-page":"109504","DOI":"10.1016\/j.ijfoodmicro.2021.109504","volume":"363","author":"M J\u00e9r\u00f4me","year":"2022","unstructured":"J\u00e9r\u00f4me M, Passerini D, Chevalier F et al (2022) Development of a rapid qPCR method to quantify lactic acid bacteria in cold-smoked salmon. Int J Food Microbiol 363:109504\u2013109511. https:\/\/doi.org\/10.1016\/j.ijfoodmicro.2021.109504","journal-title":"Int J Food Microbiol"},{"issue":"6","key":"10360_CR34","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00284-011-9920-6","volume":"62","author":"SY Chen","year":"2011","unstructured":"Chen SY, Zhang RG, Duan GC et al (2011) Food-grade expression of Helicobacter pylori UreB subunit in Lactococcus lactis and its immunoreactivity. Curr Microbiol 62(6):1726\u20131731. https:\/\/doi.org\/10.1007\/s00284-011-9920-6","journal-title":"Curr Microbiol"},{"issue":"1","key":"10360_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12896-017-0345-6","volume":"17","author":"N Sun","year":"2017","unstructured":"Sun N, Zhang RG, Duan GC et al (2017) An engineered food-grade Lactococcus lactis strain for production and delivery of heat-labile enterotoxin B subunit to mucosal sites. BMC Biotechnol 17(1):25\u201330. https:\/\/doi.org\/10.1186\/s12896-017-0345-6","journal-title":"BMC Biotechnol"},{"issue":"38","key":"10360_CR36","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1016\/j.vaccine.2011.06.099","volume":"29","author":"KY Liu","year":"2011","unstructured":"Liu KY, Shi Y, Luo P et al (2011) Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model. Vaccine 29(38):6679\u20136685. https:\/\/doi.org\/10.1016\/j.vaccine.2011.06.099","journal-title":"Vaccine"},{"issue":"31","key":"10360_CR37","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1016\/j.vaccine.2019.06.026","volume":"37","author":"SS Song","year":"2019","unstructured":"Song SS, Li PF, Zhang RH et al (2019) Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses. Vaccine 37(31):4364\u20134369. https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.026","journal-title":"Vaccine"},{"issue":"2","key":"10360_CR38","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/jmv.25303","volume":"91","author":"AH Mohseni","year":"2019","unstructured":"Mohseni AH, Razavilar V, Keyvani H et al (2019) Oral immunization with recombinant Lactococcus lactis NZ9000 expressing human papillomavirus type 16 E7 antigen and evaluation of its immune effects in female C57BL\/6 mice. J Med Virol 91(2):296\u2013307. https:\/\/doi.org\/10.1002\/jmv.25303","journal-title":"J Med Virol"},{"key":"10360_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jbiotec.2017.08.011","volume":"259","author":"YL Jiang","year":"2017","unstructured":"Jiang YL, Yang GL, Wang Q et al (2017) Molecular mechanisms underlying protection against H9N2 influenza virus challenge in mice by recombinant Lactobacillus plantarum with surface displayed HA2-LTB. J Biotechnol 259:6\u201314. https:\/\/doi.org\/10.1016\/j.jbiotec.2017.08.011","journal-title":"J Biotechnol"},{"issue":"6","key":"10360_CR40","doi-asserted-by":"publisher","first-page":"e12428","DOI":"10.1111\/hel.12428","volume":"22","author":"L Guo","year":"2017","unstructured":"Guo L, Yin RT, Xu GX et al (2017) Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils. Helicobacter 22(6):e12428. https:\/\/doi.org\/10.1111\/hel.12428","journal-title":"Helicobacter"},{"issue":"10","key":"10360_CR41","doi-asserted-by":"publisher","first-page":"e0163743","DOI":"10.1371\/journal.pone.0163743","volume":"11","author":"MH L\u00fc","year":"2016","unstructured":"L\u00fc MH, Yu S, Deng JQ et al (2016) Efficacy of probiotic supplementation therapy for Helicobacter pylori eradication: a meta-analysis of randomized controlled trials. PLoS ONE 11(10):e0163743. https:\/\/doi.org\/10.1371\/journal.pone.0163743","journal-title":"PLoS ONE"},{"issue":"4","key":"10360_CR42","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3390\/nu13041315","volume":"13","author":"C Anania","year":"2021","unstructured":"Anania C, Di Marino VP, Olivero F et al (2021) Treatment with a probiotic mixture containing bifidobacterium animalis subsp. Lactis BB12 and Enterococcus faecium L3 for the prevention of allergic rhinitis symptoms in Children: a randomized controlled trial. Nutrients 13(4):1315\u20131325. https:\/\/doi.org\/10.3390\/nu13041315","journal-title":"Nutrients"},{"issue":"6","key":"10360_CR43","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.cgh.2006.03.028","volume":"4","author":"H Braat","year":"2006","unstructured":"Braat H, Rottiers P, Hommes DW et al (2006) A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn\u2019s disease. Clin Gastroenterol Hepatol 4(6):754\u2013759. https:\/\/doi.org\/10.1016\/j.cgh.2006.03.028","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"14","key":"10360_CR44","doi-asserted-by":"publisher","first-page":"5709","DOI":"10.1007\/s00253-017-8334-1","volume":"101","author":"JM Radziwill-Bienkowska","year":"2017","unstructured":"Radziwill-Bienkowska JM, Robert V, Drabot K et al (2017) Contribution of plasmid-encoded peptidase S8 (PrtP) to adhesion and transit in the gut of Lactococcus lactis IBB477 strain. Appl Microbiol Biotechnol 101(14):5709\u20135721. https:\/\/doi.org\/10.1007\/s00253-017-8334-1","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"10360_CR45","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1574-6941.2011.01069.x","volume":"76","author":"A Dobson","year":"2011","unstructured":"Dobson A, Crispie F, Rea MC et al (2011) Fate and efficacy of lacticin 3147-producing Lactococcus lactis in the mammalian gastrointestinal tract. FEMS Microbiol Ecol 76(3):602\u2013614. https:\/\/doi.org\/10.1111\/j.1574-6941.2011.01069.x","journal-title":"FEMS Microbiol Ecol"},{"issue":"11","key":"10360_CR46","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/1348-0421.12657","volume":"62","author":"PC Garc\u00eda","year":"2018","unstructured":"Garc\u00eda PC, Paillavil BA, Scioscia N et al (2018) Clinical and microbiological response of mice to intranasal inoculation with Lactococcus lactis expressing Group A Streptococcus antigens, to be used as an anti-streptococcal vaccine. Microbiol Immunol 62(11):711\u2013719. https:\/\/doi.org\/10.1111\/1348-0421.12657","journal-title":"Microbiol Immunol"},{"issue":"1","key":"10360_CR47","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.1038\/s41598-018-24879-x","volume":"8","author":"XY Peng","year":"2018","unstructured":"Peng XY, Zhang RG, Duan GG et al (2018) Production and delivery of Helicobacter pylori NapA in Lactococcus lactis and its protective efficacy and immune modulatory activity. Sci Rep 8(1):6435\u20136446. https:\/\/doi.org\/10.1038\/s41598-018-24879-x","journal-title":"Sci Rep"},{"issue":"2","key":"10360_CR48","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.micinf.2005.07.010","volume":"8","author":"J Nystr\u00f6m","year":"2006","unstructured":"Nystr\u00f6m J, Raghavan S, Svennerholm AM (2006) Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice. Microbes Infect 8(2):442\u2013449. https:\/\/doi.org\/10.1016\/j.micinf.2005.07.010","journal-title":"Microbes Infect"},{"issue":"14","key":"10360_CR49","doi-asserted-by":"publisher","first-page":"6219","DOI":"10.1007\/s00253-016-7333-y","volume":"100","author":"W Liu","year":"2016","unstructured":"Liu W, Tan ZL, Xue JF et al (2016) Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection. Appl Microbiol Biotechnol 100(14):6219\u20136229. https:\/\/doi.org\/10.1007\/s00253-016-7333-y","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"10360_CR50","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10529-017-2502-3","volume":"40","author":"RG Zhang","year":"2018","unstructured":"Zhang RG, Wang C, Cheng WB et al (2018) Delivery of Helicobacter pylori HpaA to gastrointestinal mucosal immune sites using Lactococcus lactis and its immune efficacy in mice. Biotech Lett 40(3):585\u2013590. https:\/\/doi.org\/10.1007\/s10529-017-2502-3","journal-title":"Biotech Lett"},{"key":"10360_CR51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cytogfr.2018.04.001","volume":"41","author":"P Ro\u017eman","year":"2018","unstructured":"Ro\u017eman P, \u0160vajger U (2018) The tolerogenic role of IFN-gamma. Cytokine Growth Factor Rev 41:40\u201353. https:\/\/doi.org\/10.1016\/j.cytogfr.2018.04.001","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"10360_CR52","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/cells8090982","volume":"8","author":"XY Peng","year":"2019","unstructured":"Peng XY, Zhang RG, Chen W et al (2019) E. coli enterotoxin LtB enhances vaccine-induced anti-H. pylori protection by promoting leukocyte migration into gastric mucus via inflammatory lesions. Cells 8(9):982\u2013999. https:\/\/doi.org\/10.3390\/cells8090982","journal-title":"Cells"},{"issue":"1","key":"10360_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1523-5378.2010.00812.x","volume":"16","author":"S Kabir","year":"2011","unstructured":"Kabir S (2011) The role of interleukin-17 in the Helicobacter pylori induced infection and immunity. Helicobacter 16(1):1\u20138. https:\/\/doi.org\/10.1111\/j.1523-5378.2010.00812.x","journal-title":"Helicobacter"},{"issue":"6","key":"10360_CR54","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s12602-021-09847-8","volume":"13","author":"TT Wang","year":"2021","unstructured":"Wang TT, Wang ZH, Mi JL et al (2021) Recombinant avian \u03b2-defensin produced by food-grade Lactococcus as a novel and potent immunological enhancer adjuvant for avian vaccine. Probiotics Antimicrob Proteins 13(6):1833\u20131846. https:\/\/doi.org\/10.1007\/s12602-021-09847-8","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"10","key":"10360_CR55","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1080\/21645515.2021.1934354","volume":"17","author":"GG Guerrero Manriquez","year":"2021","unstructured":"Guerrero Manriquez GG, Tuero I (2021) Adjuvants: friends in vaccine formulations against infectious diseases. Hum Vaccin Immunother 17(10):3539\u20133550. https:\/\/doi.org\/10.1080\/21645515.2021.1934354","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10360_CR56","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4161\/bioe.24761","volume":"4","author":"L Liu","year":"2013","unstructured":"Liu L, Yang HQ, Shin HD et al (2013) How to achieve high-level expression of microbial enzymes: strategies and perspectives. Bioengineered 4(4):212\u2013223. https:\/\/doi.org\/10.4161\/bioe.24761","journal-title":"Bioengineered"},{"issue":"8","key":"10360_CR57","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/pro.3907","volume":"29","author":"S Zarzhitsky","year":"2020","unstructured":"Zarzhitsky S, Jiang A, Stanley E, E, et al (2020) Harnessing synthetic biology to enhance heterologous protein expression. Protein Sci 29(8):1698\u20131706. https:\/\/doi.org\/10.1002\/pro.3907","journal-title":"Protein Sci"},{"issue":"17","key":"10360_CR58","doi-asserted-by":"publisher","first-page":"6887","DOI":"10.1002\/anie.201916598","volume":"59","author":"JB Solomon","year":"2020","unstructured":"Solomon JB, Lee CC, Jasniewski AJ et al (2020) Heterologous expression and engineering of the nitrogenase cofactor biosynthesis scaffold NifEN. Angew Chem Int Ed Engl 59(17):6887\u20136893. https:\/\/doi.org\/10.1002\/anie.201916598","journal-title":"Angew Chem Int Ed Engl"},{"key":"10360_CR59","doi-asserted-by":"publisher","first-page":"894206","DOI":"10.3389\/fimmu.2022.894206","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang X, Sang SL, Guan Q et al (2022) Oral administration of a Shigella 2aT32-based vaccine expressing UreB-HspA fusion antigen with and without parenteral rUreB-HspA boost confers protection against Helicobacter pylori in mice model. Front Immunol 13:894206\u2013894215. https:\/\/doi.org\/10.3389\/fimmu.2022.894206","journal-title":"Front Immunol"},{"issue":"4","key":"10360_CR60","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1586\/erv.13.20","volume":"12","author":"P Sutton","year":"2013","unstructured":"Sutton P, Chionh YT (2013) Why can\u2019t we make an effective vaccine against Helicobacter pylori? Expert Rev Vaccines 12(4):433\u2013441. https:\/\/doi.org\/10.1586\/erv.13.20","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"10360_CR61","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1073\/pnas.1424924112","volume":"112","author":"F Bagnoli","year":"2015","unstructured":"Bagnoli F, Fontana MR, Soldaini E et al (2015) Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus. Proc Natl Acad Sci USA 112(12):3680\u20133685. https:\/\/doi.org\/10.1073\/pnas.1424924112","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-024-10360-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-024-10360-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-024-10360-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:43:56Z","timestamp":1763642636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-024-10360-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10360"],"URL":"https:\/\/doi.org\/10.1007\/s12602-024-10360-x","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"3 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Ethical and Experimental Committee of West China Hospital, Sichuan University, and the ethical committee approval reference number is 20220113002. All laboratory animal studies adhered to the 3R principle to avoid unnecessary suffering of the animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}